Company: MGLD
Filing Date: 2025-09-19
Form Type: 10-K
Source: 0001493152-25-014286
Chunk: 187

Company: Marygold Companies, Inc.
Filing Date: 2025-09-19
Form: 10-K
Item: Item 1A
Chunk 187
---
 of restricted stock, stock appreciation rights, options or warrants to purchase our
common stock in the future and those shares of restricted stock, options or warrants are exercised or as the shares of restricted stock
vest, our stockholders may experience further dilution. Holders of shares of our common stock have no preemptive rights that entitle
such holders to purchase their pro rata share of any offering of shares of any class or series and, therefore, such sales or offerings
could result in increased dilution to our stockholders.

Shares
to be issued in future equity offerings could cause the market price of our common stock to decline and could have an adverse effect
on our earnings per share. In addition, future sales of our common stock or other securities in the public markets, or the perception
that these sales may occur, could cause the market price of our common stock to decline, and could materially impair our ability to raise
capital through the sale of additional securities.

The
market price of our common stock could decline due to sales, or the announcements of proposed sales, of a large number of common stock
in the market, including sales of common stock by our large stockholders, or the perception that these sales could occur. These sales
or the perception that these sales could occur could also depress the market price of our common stock and impair our ability to raise
capital through the sale of additional equity securities or make it more difficult or impossible for us to sell equity securities in
the future at a time and price that we deem appropriate. We cannot predict the effect that future sales of common stock or other equity-related
securities would have on the market price of our common stock.

On
March 7, 2025, we entered into an Equity Distribution Agreement with Maxim pursuant to which we may offer and sell shares of our common
stock to or through Maxim, as sales agent or principal, and will be sold in “at the market offerings.” Although we have not
sold any shares pursuant to such agreement as of the date of the filing of this Form 10-K, we may do so in the future subject to certain
limitations in the Equity Distribution Agreement and compliance with applicable law. We may sell up to 4.6 million shares from time to
time pursuant to the Equity Distribution Agreement. The issuance from time to time of shares pursuant to this agreement could have the
effect of depressing the market price, increasing the volatility of our shares, and result in dilution to existing stockholders.

Our
board of